The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sofosbuvir-based therapy in patients with chronic hepatitis C virus infection and malignancies: A prospective study of 143 patients.
 
Harrys A. Torres
Consulting or Advisory Role - Dynavax Technologies; Gilead Sciences; Merck
Research Funding - Gilead Sciences (Inst); Merck (Inst)
 
Minas P. Economides
No Relationships to Disclose
 
Andreas Kyvernitakis
No Relationships to Disclose
 
Parag Mahale
No Relationships to Disclose
 
Jeff Hosry
No Relationships to Disclose
 
Aung Naing
Research Funding - Amplimmune; ARMO BioSciences; Atterocor; Baxter (I); EMD Serono; Healios; Incyte; Karyopharm Therapeutics; MedImmune; NCI; Novartis; Regeneron
Travel, Accommodations, Expenses - ARMO BioSciences
 
Francesco Turturro
No Relationships to Disclose
 
Ahmed Omar Kaseb
No Relationships to Disclose
 
Issam I. Raad
Stock and Other Ownership Interests - Citius; inVentiv Health; Novel Anti-Infective Tech
Honoraria - Pfizer
Patents, Royalties, Other Intellectual Property - Citius; Cook Medical; Novel Anti-Infective Tech
Travel, Accommodations, Expenses - Pfizer
 
Bruno Palma Granwehr
Research Funding - Gilead Sciences; Merck